MedPath
HSA Approval

DEXALTIN ORAL PASTE 1 mg/g

SIN05232P

DEXALTIN ORAL PASTE 1 mg/g

DEXALTIN ORAL PASTE 1 mg/g

November 30, 1990

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

PASTE

SUBMUCOSAL

Medical Information

A01AC02

dexamethasone

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

NIPPON KAYAKU CO LTD

Teika Pharmaceutical Co., Ltd. Shinjo Factory

Active Ingredients

DEXAMETHASONE

1 mg/g

Dexamethasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXALTIN ORAL PASTE 1 mg/g - HSA Approval | MedPath